HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 148 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $981,000 | -18.4% | 20,118 | -18.6% | 0.17% | +26.9% |
| Q1 2022 | $1,202,000 | +14.2% | 24,702 | 0.0% | 0.13% | -11.8% |
| Q4 2021 | $1,053,000 | -8.8% | 24,702 | -17.9% | 0.15% | +15.2% |
| Q3 2021 | $1,154,000 | +20.7% | 30,101 | -11.1% | 0.13% | +24.5% |
| Q2 2021 | $956,000 | – | 33,853 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |